Inhaling concentrated clouds of insulin through the nose twice per day may have a slowing effect on the memory loss associated with Alzheimer’s, potentially reversing a degree of the damage in some cases, according to the early results of a new study.
The study involved a group of 104 people in total and can therefore only be considered as preliminary, though the findings are indeed promising. Early results have suggested that the use of a safe, cheap and simple measure could in fact boost the metabolism in key areas of the brain, which in turn may hold off the devastating effects of the neurological disorder in its early stages.
Insulin is of course the metabolic hormone known most commonly for its role when treating diabetes, but it has been found over recent years that those with diabetes or the underlying causes leading up to diabetes may in fact be far more prone to developing Alzheimer’s. Needless to say, this prompted scientists to consider whether or not insulin may prove effective to treat the latter.
After two months of the treatment, those who were given 20mg doses of insulin saw improved performance on memory tests. Such improvements continued over the course of four months and were still noticeable two months after the treatment was withdrawn.
It will of course take a much lager study involving more patients over a longer period to find out exactly how effective the treatment may be, though at present appears to be the best hope for millions in recent years.